Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong · Delayed Price · Currency is HKD 42.40
-0.42 (-0.98%)
At close: Jan 20, 2026
Sunshine Lake Pharma Market Cap
Sunshine Lake Pharma has a market cap or net worth of 24.42 billion as of January 20, 2026. Its market cap has increased by 168.43% in one year.
Market Cap
24.42B
Enterprise Value
25.30B
Revenue
3.96B
Ranking
n/a
PE Ratio
19.15
Stock Price
42.40
Market Cap Chart
Since December 29, 2015, Sunshine Lake Pharma's market cap has increased from 6.55B to 24.42B, an increase of 272.73%. That is a compound annual growth rate of 13.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 24.42B | -7.04% |
| Dec 31, 2025 | 26.27B | 212.32% |
| Dec 31, 2024 | 8.41B | 0.74% |
| Dec 29, 2023 | 8.35B | 46.00% |
| Dec 30, 2022 | 5.72B | 6.56% |
| Dec 31, 2021 | 5.37B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |